Since both JNK and p38 MAPK phosphorylate MCL1, and target it for proteasomal degradation [56, 57], it is conceivable that along with NOXA induction, this may represent an additional mechanism of P1446A toxicity in CLL. This evidence concerns the gene MCL1 and B-cell chronic lymphocytic leukemia.